Understanding and treating the inflammatory adverse events of cancer immunotherapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Understanding and treating the inflammatory adverse events of cancer immunotherapy

Published:2021-03 Issue:6 Volume:184 Page:1575-1588
ISSN:0092-8674
Container-title:Cell
language:en
Short-container-title:Cell

Author:

Dougan Michael,Luoma Adrienne M.,Dougan Stephanie K.,Wucherpfennig Kai W.

Funder

Melanoma Research Alliance

National Institutes of Health

American Cancer Society

American Gastroenterological Association

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference86 articles.

1. Outcomes of vedolizumab therapy in patients with immune checkpoint inhibitor-induced colitis: a multi-center study;Abu-Sbeih;J. Immunother. Cancer,2018

2. Immune Checkpoint Inhibitor Therapy in Patients With Preexisting Inflammatory Bowel Disease;Abu-Sbeih;J. Clin. Oncol.,2019

3. Endogenous Glucocorticoid Signaling Regulates CD8+ T Cell Differentiation and Development of Dysfunction in the Tumor Microenvironment;Acharya;Immunity,2020

4. Interferon γ and Its Important Roles in Promoting and Inhibiting Spontaneous and Therapeutic Cancer Immunity;Alspach;Cold Spring Harb. Perspect. Biol.,2019

5. Impact of Baseline Steroids on Efficacy of Programmed Cell Death-1 and Programmed Death-Ligand 1 Blockade in Patients With Non-Small-Cell Lung Cancer;Arbour;J. Clin. Oncol.,2018

Cited by 147 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cancer Therapy-induced Dermatotoxicity as a Window to Understanding Skin Immunity;Hematology/Oncology Clinics of North America;2024-10

2. Successful replacement for recurrent nasopharyngeal carcinoma with cholecystitis induced by PD-1 antibody: a case report;Immunotherapy;2024-09-04

3. Immuncheckpoint-Inhibition – Basiswissen für die klinische Praxis;Radiopraxis;2024-09

4. Anticancer peptides as novel immunomodulatory therapeutic candidates for cancer treatment;Exploration of Targeted Anti-tumor Therapy;2024-08-21

5. Peripheral nervous system immune-related adverse events due to checkpoint inhibition;Nature Reviews Neurology;2024-08-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3